354 related articles for article (PubMed ID: 31175863)
1. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.
Das KK; Geng X; Brown JW; Morales-Oyarvide V; Huynh T; Pergolini I; Pitman MB; Ferrone C; Al Efishat M; Haviland D; Thompson E; Wolfgang C; Lennon AM; Allen P; Lillemoe KD; Fields RC; Hawkins WG; Liu J; Castillo CF; Das KM; Mino-Kenudson M
Gastroenterology; 2019 Sep; 157(3):720-730.e2. PubMed ID: 31175863
[TBL] [Abstract][Full Text] [Related]
2. Cytology adds value to monoclonal antibody Das-1 testing for detection of high-risk pancreatic cysts.
Heidarian A; Das KK; Mino-Kenudson M; Fernandez-Del Castillo C; Pitman MB
J Am Soc Cytopathol; 2021; 10(3):249-254. PubMed ID: 33541830
[TBL] [Abstract][Full Text] [Related]
3. Transmembrane mucin MUC13 distinguishes intraductal papillary mucinous neoplasms from non-mucinous cysts and is associated with high-risk lesions.
Stiles ZE; Khan S; Patton KT; Jaggi M; Behrman SW; Chauhan SC
HPB (Oxford); 2019 Jan; 21(1):87-95. PubMed ID: 30115565
[TBL] [Abstract][Full Text] [Related]
4. mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN).
Das KK; Xiao H; Geng X; Fernandez-Del-Castillo C; Morales-Oyarvide V; Daglilar E; Forcione DG; Bounds BC; Brugge WR; Pitman MB; Mino-Kenudson M; Das KM
Gut; 2014 Oct; 63(10):1626-34. PubMed ID: 24277729
[TBL] [Abstract][Full Text] [Related]
5. Validation of the clinical utility of 4 guidelines in the initial triage of mucinous cystic lesions of the pancreas based on cross-sectional imaging: Experience with 188 surgically-treated patients.
Park RHS; Lim GRS; Wu JJY; Koh YX; Teo JY; Cheow PC; Chan CY; Ooi LLPJ; Chung AYF; Goh BKP
Eur J Surg Oncol; 2020 Nov; 46(11):2114-2121. PubMed ID: 32828582
[TBL] [Abstract][Full Text] [Related]
6. Safety of endoscopic ultrasound-guided ethanol ablation for pancreatic cystic lesions: A single-center experience of 214 patients.
Choi JH; Lee SH; Choi YH; You MS; Shin BS; Paik WH; Ryu JK; Kim YT
Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):562-568. PubMed ID: 31551143
[TBL] [Abstract][Full Text] [Related]
7. Synchronous pancreatic solid pseudopapillary neoplasm and intraductal papillary mucinous neoplasm.
Hirabayashi K; Zamboni G; Ito H; Ogawa M; Kawaguchi Y; Yamashita T; Nakagohri T; Nakamura N
World J Gastroenterol; 2013 Jun; 19(21):3358-63. PubMed ID: 23745041
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of the utility of 18-FDG PET in the preoperative evaluation of IPMNs and cystic lesions of the pancreas.
Srinivasan N; Koh YX; Goh BKP
Surgery; 2019 May; 165(5):929-937. PubMed ID: 30577952
[TBL] [Abstract][Full Text] [Related]
9. Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms.
Mukewar S; de Pretis N; Aryal-Khanal A; Ahmed N; Sah R; Enders F; Larson JJ; Levy MJ; Takahashi N; Topazian M; Pearson R; Vege SS; Chari ST
Gut; 2017 Oct; 66(10):1811-1817. PubMed ID: 27390303
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of mucinous nonneoplastic cysts of the pancreas.
Nadig SN; Pedrosa I; Goldsmith JD; Callery MP; Vollmer CM
Pancreas; 2012 Apr; 41(3):441-6. PubMed ID: 22015974
[TBL] [Abstract][Full Text] [Related]
11. Accuracy and agreement of a large panel of endosonographers for endomicroscopy-guided virtual biopsy of pancreatic cystic lesions.
Machicado JD; Napoleon B; Lennon AM; El-Dika S; Pereira SP; Tan D; Pannala R; Girotra M; Kongkam P; Bertani H; Feng Y; Sijie H; Zhong N; Valantin V; Leblanc S; Hinton A; Krishna SG
Pancreatology; 2022 Nov; 22(7):994-1002. PubMed ID: 36089484
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with misdiagnosis of preoperative endoscopic ultrasound in patients with pancreatic cystic neoplasms undergoing surgical resection.
Ohno E; Ishikawa T; Mizutani Y; Iida T; Uetsuki K; Yashika J; Yamada K; Gibo N; Aoki T; Kawashima H
J Med Ultrason (2001); 2022 Jul; 49(3):433-441. PubMed ID: 35411413
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cyst fluid interleukin-1 beta (IL-1β) level in predicting the risk of malignancy in pancreatic cysts.
Abdellah TA; Shalaby SM; Salem AA; Yousef TM; Saleh SA; Saleh HH; Zaghloul MS; El-Nady MA
Egypt J Immunol; 2022 Oct; 29(4):75-83. PubMed ID: 36198105
[TBL] [Abstract][Full Text] [Related]
14. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.
Yip-Schneider MT; Wu H; Dumas RP; Hancock BA; Agaram N; Radovich M; Schmidt CM
J Am Coll Surg; 2014 Apr; 218(4):608-17. PubMed ID: 24491241
[TBL] [Abstract][Full Text] [Related]
16. Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size.
Han Y; Lee H; Kang JS; Kim JR; Kim HS; Lee JM; Lee KB; Kwon W; Kim SW; Jang JY
Gastroenterology; 2018 Feb; 154(3):576-584. PubMed ID: 29074452
[TBL] [Abstract][Full Text] [Related]
17. Sendai and Fukuoka Consensus Guidelines Identify Advanced Neoplasia in Patients With Suspected Mucinous Cystic Neoplasms of the Pancreas.
Kaimakliotis P; Riff B; Pourmand K; Chandrasekhara V; Furth EE; Siegelman ES; Drebin J; Vollmer CM; Kochman ML; Ginsberg GG; Ahmad NA
Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1808-15. PubMed ID: 25818077
[TBL] [Abstract][Full Text] [Related]
18. Lower cyst fluid carcinoembryonic antigen cutoff is helpful in the differential diagnosis of mucinous versus non-mucinous pancreatic cysts.
Sharma RK; Bush N; Rana SS; Srinivasan R; Nada R; Gupta R; Rana S; Singh T
Indian J Gastroenterol; 2022 Aug; 41(4):397-404. PubMed ID: 36057043
[TBL] [Abstract][Full Text] [Related]
19. Humoral Predictors of Malignancy in IPMN: A Review of the Literature.
Nista EC; Schepis T; Candelli M; Giuli L; Pignataro G; Franceschi F; Gasbarrini A; Ojetti V
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884643
[TBL] [Abstract][Full Text] [Related]
20. Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer.
Nguyen AH; Toste PA; Farrell JJ; Clerkin BM; Williams J; Muthusamy VR; Watson RR; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
J Gastrointest Surg; 2015 Feb; 19(2):258-65. PubMed ID: 25373706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]